Skip to main content
. 2023 Mar 2;8(2):e00927-22. doi: 10.1128/msystems.00927-22

TABLE 2.

Subunit vaccines approved for use in at least one country (310) as of 2 December 2022 (6)

Vaccine Company Platform
Zifivax Anhui Zhifei Longcom Protein subunit
Noora Bagheiat-allah University of Medical Sciences Protein subunit
Corbevax Biological E. Limited Protein subunit
Abdala Center for Genetic Engineering and Biotechnology (CIGB) Protein subunit
Soberana 02 Instituto Finlay de Vacunas Cuba Protein subunit
Soberana Plus Instituto Finlay de Vacunas Cuba Protein subunit
V-01 Livzon Mabpharm Inc. Protein subunit
Covifenz Medicago VLP
MVC-COV1901 Medigen Protein subunit
Recombinant SARS-CoV-2 (CHO cell) National Vaccine and Serum Institute Protein subunit
Nuvaxovid Novavax Protein subunit
IndoVac PT Bio Farma Protein subunit
Razi Cov Pars Razi Vaccine and Serum Research Institute Protein subunit
VidPrevtyn Beta Sanofi/GSK Protein subunit
COVOVAX (Novavax formulation) Serum Institute of India Protein subunit
SKYCovione SK Bioscience Co. Ltd. Protein subunit
TAK-019 (Novavax formulation) Takeda Protein subunit
SpikoGen Vaxine/CinnaGen Co. Protein subunit
Aurora-CoV Vector State Research Center of Virology and Biotechnology Protein subunit
EpiVacCorona Vector State Research Center of Virology and Biotechnology Protein subunit